Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone in MPO-associated pulmonary fibrosis
NCT03385668Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2018
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pirfenidone in pulmonary fibrosis (PF), sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2018; status: completed.
02
Drugs
pirfenidone
03
Conditions
pulmonary fibrosis (PF)
Beyond the preview
Go deeper on NCT03385668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03385668.